L. Kahana

发表

The effect of race on access and outcome in transplantation.

G. Danovitch, B. L. Kasiske, S R Alexander, 1991, The New England journal of medicine.

Clinical aspects of atypical mycobacterial infection.

F. Cole, H. Richardson, L. Kahana, 1975, Canadian Medical Association journal.

Pneumonitis due to Mycobacterium avium complex in hot tub water: infection or hypersensitivity?

L. Kahana, J. Kay, 1997, Chest.

Mycobacterium avium complex infection in an immunocompetent young adult related to hot tub exposure.

M. Yakrus, S. Waserman, L. Kahana, 1997, Chest.

Ciprofloxacin in Patients with Mycobacterial Infections: Experience in 15 Patients

M. Spino, L. Kahana, Leo M. Kahana, 1991, DICP : the annals of pharmacotherapy.

Safety of inhaled corticosteroids delivered by plastic and metal spacers

M. Newhouse, I. Amirav, L. Kahana, 2003, Archives of disease in childhood.

Diffuse smooth muscle proliferation of the lungs with severe pulmonary hypertension.

L. Kahana, J. Kay, C. Rihal, 1996, Human pathology.

Hepatotoxicity of antituberculosis drugs.

L. Kahana, 1996, Thorax.

The evaluation of candidates for renal transplantation. The current practice of U.S. transplant centers.

B. Kasiske, G. Danovitch, S. Alexander, 1994, Transplantation.

Endocrine Manifestations of Intracranial Extrasellar Lesions

H. Lebovitz, L. Kahana, J. Oppenheimer, 1962 .

Relative Performance of Specific and Nonspecific Fluorescence Polarization Immunoassay for Cyclosporine in Transplant Patients

E. Spoto, L. Kahana, D. Shires, 1992, Therapeutic drug monitoring.

Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper‐thyroidism and back to hypothyroidism

O. Sadeh, L. Kahana, E. Baron, 1992, Clinical endocrinology.

Tuberculosis in dialysis patients.

A. Shimizu, L. Kahana, M. C. Belcon, 1982, Clinical nephrology.

Hypothalamic-pituitary sarcoidosis: A report on four patients, one with prolonged remission of diabetes insipidus following steroid therapy☆

C. Shealy, L. Kahana, H. McPherson, 1961 .

The problem of drug resistance in tuberculosis.

L. Kahana, 1996, Chest.

Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.

L. Kahana, D. Shires, S. Weinstein, 1996, Clinical transplantation.

Ethambutol in tuberculosis.

L. Kahana, 1990, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.

Y. Seifu, K. Budde, G. Knoll, 2005, Transplantation proceedings.

Long-term corticosteroid therapy in Hurler syndrome.

S. L. Wolfson, J. Harris, L. Kahana, 1963, American journal of diseases of children.

Cushing's syndrome with malignant corticotropin-producing tumor: Remission and relapse following subtotal adrenalectomy and tumor resection

L. Kahana, F. Engel, 1963 .

Glomerulonephritis and virus-like particles associated with prostatic cancer.

R. Finney, R. Pascal, L. Kahana, 1980, Human pathology.

Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase.

M. H. Gault, L. Kahana, M. Cohen, 1967, Canadian Medical Association journal.

Seasonal, sexual and age-related variation in the blood composition of the brown pelican (Pelecanus occidentalis)

Steven H. Wolf, R. Schreiber, L. Kahana, 1985 .

HASHIMOTO'S THYROIDITIS. REPORT OF CASE IN A CHILD.

L. Kahana, S. Wolfson, 1965, The Journal of the Florida Medical Association. Florida Medical Association.

Four-year experience with exclusive use of cytomegalovirus antibody (CMV-Ab)-negative donors for CMV-Ab-negative kidney recipients.

L. Kahana, D. Shires, S. Weinstein, 1988, Transplantation proceedings.

OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies.

A. Monaco, D. Abramowicz, P. Kinnaert, 1995, Transplantation proceedings.

Uses of orthoclone OKT3 for prophylaxis of rejection and induction in initial nonfunction in kidney transplantation.

L. Kahana, D. Shires, S. Weinstein, 1990, Transplantation proceedings.

OKT3 prophylaxis versus conventional drug therapy: single-center perspective, part of a multicenter trial.

L. Kahana, D. Shires, S. Weinstein, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

OKT3 rescue in refractory renal rejection.

L. Kahana, J. Baxter, 1987, Nephron.

Toxic ocular effects of ethambutol.

L. Kahana, 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival.

A. Monaco, Shu-chen Wu, P. Vereerstraeten, 1996, Kidney international.

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.

K. Lamborn, R. Stratta, A. Gaber, 1998, Transplantation.

Needle Biopsy as an Aid to the Precise Diagnosis of Intrathoracic Disease.

L. Kahana, M. Aronovitch, M. Groszman, 1963, Canadian Medical Association journal.